Company: ARMP
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001558370-25-011235
Chunk: 11

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part II, Item 2
Chunk 11
---
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS  

None.

Item 3. DEFAULTS UPON SENIOR SECURITIES 

None.

Item 4. MINE SAFETY DISCLOSURES

Not applicable.

Item 5. OTHER INFORMATION 

Insider Trading Arrangements

During the three months ended June 30, 2025, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement,” and none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a “non-Rule 10b5-1 trading arrangement” (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended). 

Item 6. EXHIBITS  

​

Number    Description3.1​Amended and Restated Articles of Incorporation of the Company, as amended (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q, filed with the SEC on November 16, 2015).​​​3.2​Articles of Amendment to Amended and Restated Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K (File No. 001-37544), filed with the SEC on April 24, 2017).​​​3.3​Statement of Correction to Articles of Amendment to Amended and Restated Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q, filed on November 8, 2018).​​​3.4​Articles of Amendment to Amended and Restated Articles of Incorporation of the registrant (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on December 18, 2018).​​​